
Breton2 mg
Drug International Ltd.
Tulobuterol Hydrochloride is a selective, long-acting beta-2 adrenergic receptor agonist used as a bronchodilator.
Tulobuterol Hydrochloride is a selective, long-acting beta-2 adrenergic receptor agonist used as a bronchodilator. Its established and guideline-supported uses include:
Tulobuterol Hydrochloride is intended for regular, scheduled maintenance dosing and is not a fast-acting rescue medicine; a short-acting bronchodilator should always be available separately for sudden or acute symptoms.
| Indication | Dose |
|---|---|
| Bronchial asthma, chronic bronchitis, asthmatic bronchitis, pulmonary emphysema (maintenance) | Usual dose of Tulobuterol Hydrochloride: 2 mg (one tablet) orally twice daily; elderly or sensitive patients may start at 1 mg twice daily and increase to 2 mg twice daily after 7-10 days if needed. Maximum recommended dose is 6 mg per day in divided doses. |
| Age Group | Dose |
|---|---|
| 1-6 years | 2.5-5 mL twice daily |
| 6-12 years | 5-10 mL twice daily |
| Above 12 years | 10-20 mL twice daily |
An approximate weight-based dose of 40-80 mcg/kg/day in two divided doses may also be used under medical supervision. Doses of Tulobuterol Hydrochloride should always be individualized by the prescribing physician based on age, severity, and response.
Tulobuterol Hydrochloride is eliminated mainly by the kidneys and undergoes hepatic metabolism; therefore, caution and dose reduction should be considered in patients with significant renal or hepatic impairment, under medical supervision.
Where a transdermal patch of Tulobuterol Hydrochloride is used, one patch is typically applied once daily to clean, dry, non-irritated skin; the old patch must be removed before a new one is applied, and application sites should be rotated to reduce skin irritation.
Common and clinically important side effects of Tulobuterol Hydrochloride include:
Tremor is dose-related and tends to diminish with continued use. Patients should seek medical advice if side effects are severe or persistent.
Tulobuterol Hydrochloride is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.